 |
|
The Dysregulation of Human Subjects Research
Norman Fost, MD, MPH;
Robert J. Levine, MD
JAMA. 2007;298(18):2196-2198.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
The regulatory system for protecting human subjects in research in the United States is increasingly dysfunctional. While many critics assert that research participants are inadequately protected,1-2 there are increasing concerns that the system is overregulated, with more time and expense devoted to activities of marginal utility in protecting human research participants.3-6 In some cases these activities actually appear to be reducing protections for participants in research, by diverting energy that could be spent on more fruitful tasks and by creating disincentives to institutional review board (IRB) membership.
Undeniably the early history of research involving human subjects was dominated by scandals, including widespread egregiously unethical behavior by US physician investigators.7 In 1973, 7 years after the US government required IRBs for federally funded research, many institutions were found to be performing only perfunctory reviews.8
By 1983 a presidential commission9 found the IRB system . . . [Full Text of this Article]
Author Affiliations: University of Wisconsin School of Medicine and Public Health, Madison (Dr Fost); and Yale University School of Medicine, New Haven, Connecticut (Dr Levine).
RELATED ARTICLE
Influence of the HIPAA Privacy Rule on Health Research
Roberta B. Ness and for the Joint Policy Committee, Societies of Epidemiology
JAMA. 2007;298(18):2164-2170.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Health Research and the HIPAA Privacy Rule
Tilden
JAMA 2008;299:1259-1259.
FULL TEXT
Health Research and the HIPAA Privacy Rule
Faden et al.
JAMA 2008;299:1259-1260.
FULL TEXT
|
